Literature DB >> 19387732

Analysis of nontarget embolization mechanisms during embolization and chemoembolization procedures.

Rubén López-Benítez1, Götz M Richter, Hans-Ulrich Kauczor, Sibylle Stampfl, Juliane Kladeck, Boris A Radeleff, Martin Neukamm, Peter J Hallscheidt.   

Abstract

Complications of embolization and chemoembolization remain a problem even with the development of low-profile catheter material and the introduction of new embolization agents. In recent years many new embolization materials have become available for clinical use, so the possibilities and limitations of these new materials must be understood to allow safe and effective embolization. Although up to now some scientific work has been published reporting the basic risk of embolization procedures, the underlying pathomechanism remains the object of speculation. Besides complications like drug toxicity, allergic reactions, and bleeding of the puncture site, the characteristics of embolization materials must be known to understand the potential complications of nontarget embolization and reflux of embolization material. This article gives an overview of established and new embolization materials, their potential risks, and the underlying pathophysiology.

Entities:  

Mesh:

Year:  2009        PMID: 19387732     DOI: 10.1007/s00270-009-9568-9

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  10 in total

1.  Hepatic arterial embolization complicated by acute cholecystitis.

Authors:  Rajesh P Shah; Karen T Brown
Journal:  Semin Intervent Radiol       Date:  2011-06       Impact factor: 1.513

Review 2.  Transcatheter embolization therapy in liver cancer: an update of clinical evidences.

Authors:  Yì-Xiáng J Wáng; Thierry De Baere; Jean-Marc Idée; Sébastien Ballet
Journal:  Chin J Cancer Res       Date:  2015-04       Impact factor: 5.087

3.  In vivo imaging using polymeric nanoparticles stained with near-infrared chemiluminescent and fluorescent squaraine catenane endoperoxide.

Authors:  Jung-Jae Lee; Alexander G White; Douglas R Rice; Bradley D Smith
Journal:  Chem Commun (Camb)       Date:  2013-04-14       Impact factor: 6.222

4.  On-demand degradable embolic microspheres for immediate restoration of blood flow during image-guided embolization procedures.

Authors:  Hyunjun Choi; Bongseo Choi; Bo Yu; Weiguo Li; Monica M Matsumoto; Kathleen R Harris; Robert J Lewandowski; Andrew C Larson; Samdeep K Mouli; Dong-Hyun Kim
Journal:  Biomaterials       Date:  2020-09-24       Impact factor: 12.479

5.  Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma.

Authors:  Giorgio Greco; Tommaso Cascella; Antonio Facciorusso; Roberto Nani; Rodolfo Lanocita; Carlo Morosi; Marta Vaiani; Giuseppina Calareso; Francesca G Greco; Antonio Ragnanese; Marco A Bongini; Alfonso V Marchianò; Vincenzo Mazzaferro; Carlo Spreafico
Journal:  World J Radiol       Date:  2017-05-28

6.  Immobilized thrombin on X-ray radiopaque polyvinyl alcohol/chitosan embolic microspheres for precise localization and topical blood coagulation.

Authors:  Xiaohong Li; Xiongfa Ji; Kun Chen; Muhammad Wajid Ullah; Basen Li; Jiameng Cao; Lin Xiao; Jun Xiao; Guang Yang
Journal:  Bioact Mater       Date:  2021-01-12

7.  Fluid-dynamic control microcatheter used with glue: preliminary experience on its feasibility and safety.

Authors:  Anna Maria Ierardi; Elvira Stellato; Giuseppe Pellegrino; Cristian Bonelli; Michaela Cellina; Matteo Renzulli; Pierpaolo Biondetti; Gianpaolo Carrafiello
Journal:  Radiol Med       Date:  2022-02-18       Impact factor: 6.313

8.  Microfluidic-prepared, monodisperse, X-ray-visible, embolic microspheres for non-oncological embolization applications.

Authors:  Cyrus W Beh; Yingli Fu; Clifford R Weiss; Charles Hu; Aravind Arepally; Hai-Quan Mao; Tza-Huei Wang; Dara L Kraitchman
Journal:  Lab Chip       Date:  2020-09-01       Impact factor: 6.799

9.  Chemoembolization of hepatocellular carcinoma with HepaSphere 30-60 μm. Safety and efficacy study.

Authors:  Katerina Malagari; Maria Pomoni; Hippokratis Moschouris; Alexios Kelekis; Angelos Charokopakis; Evanthia Bouma; Themistoklis Spyridopoulos; Achilles Chatziioannou; Vlasios Sotirchos; Theodoros Karampelas; Constantin Tamvakopoulos; Dimitrios Filippiadis; Enangelos Karagiannis; Athanasios Marinis; John Koskinas; Dimitrios A Kelekis
Journal:  Cardiovasc Intervent Radiol       Date:  2013-11-22       Impact factor: 2.740

Review 10.  Endoluminal occlusion devices: technology update.

Authors:  Tobias Zander; Samantha Medina; Guillermo Montes; Lourdes Nuñez-Atahualpa; Michel Valdes; Manuel Maynar
Journal:  Med Devices (Auckl)       Date:  2014-12-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.